
March 12 (Reuters) - ViiV Healthcare:
VIIV HEALTHCARE’S INVESTIGATIONAL BROADLY NEUTRALISING ANTIBODY - N6LS - SUCCESSFULLY MAINTAINS VIRAL SUPPRESSION IN LONG-ACTING TREATMENT OF HIV
VIIV HEALTHCARE: N6LS WAS ALSO WELL TOLERATED BY PARTICIPANTS
VIIV HEALTHCARE: EMBRACE STUDY TO CONTINUE INVESTIGATING COMBINATION OF N6LS DOSED AT SIX MONTHS WITH CAB LA